EMVision Medical Devices (ASX:EMV) Secures US Ethics Approval for Pivotal Trial
EMVision Medical Devices (ASX:EMV) receives US IRB approval for pivotal trial of the emu⢠brain scanner, maintaining progress towards March 2025 activation.
EMVision Medical Devices (ASX:EMV) receives US IRB approval for pivotal trial of the emu⢠brain scanner, maintaining progress towards March 2025 activation.
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
Ramsay Health Care (ASX:RHC) announces two non-recurring items impacting its 1H FY25 financial results, including UK segment impairment and tax provision release.
Alterity Therapeutics (ASX:ATH) secures A$40 million to advance ATH434 development for Parkinsonian disorders, supported by institutional investors.
Careteq Limited (ASX:CTQ) forms a strategic partnership with MedicAlert Foundation Australia to enhance medication safety for Australians.
Wellnex Life Limited (ASX:WNX) launches a non-renounceable entitlement offer to raise $22.1 million for strategic growth and debt redemption.
BTC Health (ASX:BTC) extends partnership with Arna Pharma, securing indefinite license and royalty agreements in key markets.
Micro-X Ltd (ASX:MX1) successfully raises $3.3M through capital placement, focusing on medical imaging and strategic partnerships.
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSEĀ®’s safety in adolescent EPP patients.
Smartgroup Corporation Ltd (ASX:SIQ) secures a contract with Monash Health to provide salary packaging and novated leasing services for 25,000 employees.